BlueFive Capital: $3 Billion for AI and Biotech

BlueFive Capital: $3 Billion for AI and Biotech
On February 2, 2026, investment firm BlueFive Capital closed fundraising for the $3 billion Onyx I fund. The fund will focus on startups in the US and Europe working in AI, biotechnology, and advanced computing.

The closing of such a large fund confirms that venture capital continues to believe in the long-term potential of deep tech (DeepTech), despite volatility in public markets. Investors are looking for the next breakthrough beyond simple LLM wrappers.

Source: BlueFive / Reuters
Venture CapitalInvestmentDeepTechStartupsBiotech
« Back to News List
Chat